{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T09:20:00Z","timestamp":1791537600759,"version":"4.3.4"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Evidence from clinical trials of early pulsed field ablation (PFA) systems in treating atrial fibrillation has demonstrated their promising potential to reduce complications associated with conventional thermal modalities while maintaining efficacy. However, the lack of a fully integrated mapping system, a staple technology of most modern electrophysiology procedures, poses limitations in lesion creation and workflow options. A novel variable-loop PFA catheter integrated with an electroanatomic mapping system has been developed that allows for real-time nonfluoroscopic procedural guidance and lesion indexing as well as feedback of tissue-to-catheter proximity. AdmIRE (Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the Bosense-Webster Irreversible Electroporation Ablation System), a multicenter, single-arm, Food and Drug Administration investigational device exemption study, evaluated the long-term safety and effectiveness of this integrated PFA system in a large United States\u2013based drug-refractory symptomatic paroxysmal atrial fibrillation patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>Using the PFA catheter with a compatible electroanatomic mapping system, patients with drug-refractory symptomatic paroxysmal atrial fibrillation underwent pulmonary vein isolation. The primary safety end point was primary adverse event within 7 days of ablation. The primary effectiveness end point was a composite end point that included 12-month freedom from documented atrial tachyarrhythmia (ie, atrial fibrillation, atrial tachycardia, atrial flutter) episodes, failure to achieve pulmonary vein isolation, use of a nonstudy catheter for pulmonary vein isolation, repeat procedure (except for one redo during blanking), taking a new or previously failed class I or III antiarrhythmic drug at higher dose after blanking, or direct current cardioversion after blanking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>At 30 centers, 277 patients with paroxysmal atrial fibrillation (61.5\u00b110.3 years of age; 64.3% male) in the pivotal cohort underwent PFA. More than 25% of the procedures were performed without fluoroscopy. Median (Q1, Q3) pulmonary vein isolation procedure, fluoroscopy, and transpired PFA application times were 81.0 (61.0, 112.0), 7.1 (0.00, 14.3), and 31.0 (24.8, 40.9) minutes, respectively. The primary adverse event rate was 2.9% (8 of 272), with the most common complication being pericardial tamponade. The 12-month primary effectiveness end point was 74.6%. The 1-year freedom from atrial fibrillation, atrial tachycardia, or atrial flutter recurrence rate after blanking was 75.4%. Substantial improvements in quality of life were observed as early as 3 months after the procedure, concurrent with a reduction in multiple health care use measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>AdmIRE confirmed the safety and effectiveness of the variable-loop PFA catheter, with short procedure and PFA application times and low fluoroscopy exposure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>REGISTRATION:<\/jats:title>\n                    <jats:p>\n                      URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n                      ; Unique identifier: NCT05293639.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/circulationaha.124.070333","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T05:00:48Z","timestamp":1726030848000},"page":"1174-1186","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":155,"title":["Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the AdmIRE Pivotal Trial"],"prefix":"10.1161","volume":"150","clinical-trial-number":[{"clinical-trial-number":"nct05293639","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Vivek Y.","family":"Reddy","sequence":"first","affiliation":[{"name":"Helmsley Electrophysiology Center, Mount Sinai Fuster Heart Hospital, New York, NY (V.Y.R.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-9433","authenticated-orcid":true,"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medical Institutions, Baltimore, MD (H.C.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moussa","family":"Mansour","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston (M.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-7716","authenticated-orcid":true,"given":"Oussama","family":"Wazni","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, OH (O.W., A.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6508-4047","authenticated-orcid":true,"given":"Luigi","family":"Di Biase","sequence":"additional","affiliation":[{"name":"Montefiore Health System at Albert Einstein College of Medicine, New York, NY (L.D.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Bahu","sequence":"additional","affiliation":[{"name":"Phoenix Cardiovascular Research Group, AZ (M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Newton","sequence":"additional","affiliation":[{"name":"Memorial Health University Medical Center, Savannah, GA (D. Newton)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8852-4551","authenticated-orcid":true,"given":"Christopher F.","family":"Liu","sequence":"additional","affiliation":[{"name":"New York Presbyterian\u2013Weill Cornell Medicine, NY (C.F.L.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8556-3612","authenticated-orcid":true,"given":"William H.","family":"Sauer","sequence":"additional","affiliation":[{"name":"Brigham &amp; Women\u2019s Hospital, Boston, MA (W.H.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6915-9835","authenticated-orcid":true,"given":"Sandeep","family":"Goyal","sequence":"additional","affiliation":[{"name":"Piedmont Heart Institute, Atlanta, GA (S.G.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Iyer","sequence":"additional","affiliation":[{"name":"Marin Health Medical Center, Larkspur, CA (V.I.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8253-947X","authenticated-orcid":true,"given":"Devi","family":"Nair","sequence":"additional","affiliation":[{"name":"St. Bernard\u2019s Medical Center &amp; Arrhythmia Research Group, Jonesboro, AR (D. Nair)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9423-2261","authenticated-orcid":true,"given":"Charles","family":"Athill","sequence":"additional","affiliation":[{"name":"San Diego Cardiac Center, CA (C.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8359-1525","authenticated-orcid":true,"given":"Ayman","family":"Hussein","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Foundation, OH (O.W., A.H.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Whalen","sequence":"additional","affiliation":[{"name":"Wake Forest Baptist Health, Winston-Salem, NC (P.W.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Melby","sequence":"additional","affiliation":[{"name":"Minneapolis Heart Institute, MN (D.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5487-0728","authenticated-orcid":true,"given":"Andrea","family":"Natale","sequence":"additional","affiliation":[{"name":"Texas Cardiac Arrhythmia Research Foundation, Austin (A.N.)."},{"name":"Department of Biomedicine and Prevention, Division of Cardiology, University of Tor Vergata, Rome, Italy (A.N.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the AdmIRE Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.07.007"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008718"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2021.02.014"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.021"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad185"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.064959"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.063988"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euab090"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007781"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.008303"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae038"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004672"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2018.04.005"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.009229"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307291"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011110"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hroo.2023.09.005"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15522"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.123.012667"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.122.011780"},{"key":"e_1_3_3_22_2","unstructured":"Newton D Natale A Mansour M Nair D Senn T Reddy VY on behalf of the ADMIRE Trial Investigators. Pulsed field ablation using a variable loop circular catheter with 3D mapping integration: early outcomes of the ADMIRE study. Presented at the AF Symposium Boston MA February 2 2024."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eux274"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2023.04.002"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae090"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euac050"},{"key":"e_1_3_3_27_2","unstructured":"Reddy VY Ekanem E. Multi-national survey on the safety of the post-approval use of pulsed field ablation in 17000+ patients (MANIFEST-17K). Presented at the American Heart Association (AHA) Late Breaking & Featured Science Scientific Sessions; Philadelphia PA; November 11 2023."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw223"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.11.056"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.04.015"},{"key":"e_1_3_3_31_2","unstructured":"Massachusetts General Hospital. Safety and Effectiveness of Pulmonary Vein Isolation and Posterior Wall Ablation With Pulsed Field Energy in Patients With Paroxysmal and Persistent AF (POLARIS). ClinicalTrials.gov identifier: NCT06099730. Updated January 16 2024. https:\/\/clinicaltrials.gov\/study\/NCT06099730"},{"key":"e_1_3_3_32_2","unstructured":"Reddy VY. Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy (VIRTUE). ClinicalTrials.gov identifier: NCT06056557. Updated October 18 2023. https:\/\/clinicaltrials.gov\/study\/NCT06056557"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2024.04.090"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-022-02091-2"},{"key":"e_1_3_3_35_2","first-page":"68","article-title":"Real-world experience comparing zero versus conventional fluoroscopy catheter ablation for the treatment of symptomatic persistent atrial fibrillation.","volume":"16","author":"Metzl MD","year":"2023","unstructured":"Metzl MD, Hunter TD, Thatcher WH, Nazari J. Real-world experience comparing zero versus conventional fluoroscopy catheter ablation for the treatment of symptomatic persistent atrial fibrillation. JAFIB-EP. 2023;16:68\u201374.","journal-title":"JAFIB-EP"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/jce.15028"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.124.070333","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:24:31Z","timestamp":1748514271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.124.070333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,10,8]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.124.070333"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.124.070333","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"2024-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}